Ali Ugur Uslu1, Bahattin Aydin2, Ibrahim Serhat Icagasıoğlu3, Sevket Balta4, Köksal Deveci3, Filiz Alkan3, Gürsel Yıldız5, Ali Sahin6. 1. Department of Internal Medicine, Eskisehir Military Hospital, Eskisehir, Turkey. drauuslu@gmail.com. 2. Department of Internal Medicine, Etimesgut Military Hospital, Ankara, Turkey. 3. Department of Internal Medicine, Faculty of Medicine, Cumhuriyet University, Sivas, Turkey. 4. Department of Cardiology, Gulhane Medical Faculty, Ankara, Turkey. 5. Department of Nephrology, Faculty of Medicine, Cumhuriyet University, Sivas, Turkey. 6. Department of Rheumatology, Faculty of Medicine, Cumhuriyet University, Sivas, Turkey.
Abstract
BACKGROUND: Serum amyloid A (SAA), which is produced in the liver, acts as an apoprotein of high-density lipoprotein (HDL) accumulation in extracellular matrix of tissues and organs. SAA elevations play a significant role in the development of amyloidosis. Microalbuminuria (MAU) is the early period of amyloidosis in patients with familial Mediterranean fever (FMF). We assessed the association between SAA as an important factor for the development of amyloidosis in patients with FMF and cytokines, HDL, and MAU. METHODS: A total of 40 FMF patients diagnosed with Tel-Hashomer criteria and making regular follow-up visits at the tertiary referral center from 2012 to 2013 were included in this study, besides 40 age- and sex-matched individuals as controls. RESULTS: Compared with controls, FMF patients had higher SAA (25.20 ± 45.78 vs. 1.68 ± 0.63 ng/ml; P = 0.002). Also, FMF patients had higher MAU than controls (23.20 ± 39.86 vs. 9.40 ± 5.32 mg/day; P = 0.036). HDL was significantly lower in the patient group than in controls (39.35 ± 10.45 vs. 47.82 ± 15.31 mg/dl; P = 0.023). Interleukin-1 beta (IL-1), IL-6, and tumor necrosis factor alpha (TNF-α) levels were higher in the FMF group than in controls (P < 0.0001, P = 0.009, P = 0.003, respectively). CONCLUSIONS: Our results suggest that IL-1, IL-6, TNF-α, SAA, and HDL may serve as markers of subclinical inflammation in FMF patients. Due to increased plasma HDL levels, antiinflammatory and antioxidant effects may elevate in FMF patients.
BACKGROUND:Serum amyloid A (SAA), which is produced in the liver, acts as an apoprotein of high-density lipoprotein (HDL) accumulation in extracellular matrix of tissues and organs. SAA elevations play a significant role in the development of amyloidosis. Microalbuminuria (MAU) is the early period of amyloidosis in patients with familial Mediterranean fever (FMF). We assessed the association between SAA as an important factor for the development of amyloidosis in patients with FMF and cytokines, HDL, and MAU. METHODS: A total of 40 FMFpatients diagnosed with Tel-Hashomer criteria and making regular follow-up visits at the tertiary referral center from 2012 to 2013 were included in this study, besides 40 age- and sex-matched individuals as controls. RESULTS: Compared with controls, FMFpatients had higher SAA (25.20 ± 45.78 vs. 1.68 ± 0.63 ng/ml; P = 0.002). Also, FMFpatients had higher MAU than controls (23.20 ± 39.86 vs. 9.40 ± 5.32 mg/day; P = 0.036). HDL was significantly lower in the patient group than in controls (39.35 ± 10.45 vs. 47.82 ± 15.31 mg/dl; P = 0.023). Interleukin-1 beta (IL-1), IL-6, and tumor necrosis factor alpha (TNF-α) levels were higher in the FMF group than in controls (P < 0.0001, P = 0.009, P = 0.003, respectively). CONCLUSIONS: Our results suggest that IL-1, IL-6, TNF-α, SAA, and HDL may serve as markers of subclinical inflammation in FMFpatients. Due to increased plasma HDL levels, antiinflammatory and antioxidant effects may elevate in FMFpatients.
Authors: Nikolay A Mukhin; Lidiya V Kozlovskaya; Marina V Bogdanova; Vilen V Rameev; Sergey V Moiseev; Armine Kh Simonyan Journal: Rheumatol Int Date: 2015-01-14 Impact factor: 2.631
Authors: Menno Pruijm; Belén Ponte; Peter Vollenweider; Vincent Mooser; Fred Paccaud; Gérard Waeber; Pedro Marques-Vidal; Michel Burnier; Murielle Bochud Journal: Am J Nephrol Date: 2012-03-06 Impact factor: 3.754
Authors: Charumathi Sabanayagam; Jeannette Lee; Anoop Shankar; Su Chi Lim; Tien Y Wong; E Shyong Tai Journal: Nephrol Dial Transplant Date: 2009-11-13 Impact factor: 5.992
Authors: H J Lachmann; B Sengül; T U Yavuzşen; D R Booth; S E Booth; A Bybee; J R Gallimore; M Soytürk; S Akar; M Tunca; P N Hawkins Journal: Rheumatology (Oxford) Date: 2006-01-10 Impact factor: 7.580
Authors: Karam R Motawea; Omneya A Kandil; Joseph Varney; Merna Aboelenein; Nancy Ibrahim; Ahmed Shaheen; Lina T Khairy; Agyad Bakkour; Ali H H Muwaili; Dhuha H H Muwaili; Fatima A A Abdelmajid; Eman M S Ahmad; Mhd K Albuni; Elias Battikh; Bisher Sawaf; Sarya Swed; Safaa M A Ahmed; Dina M Awad; Jaffer Shah; Hani Aiash Journal: Health Sci Rep Date: 2022-06-13